Literature DB >> 8745136

Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up.

A Goldstein1, J Herrera.   

Abstract

All heroin addicts who registered for methadone treatment in Albuquerque in 1969-1971, 1019 in all, were the subjects of this follow-up study, conducted in 1991-1993. The cohort was almost entirely of Hispanic (Chicano) ethnicity, 86% male, with median age 27 at entry. We located 776, dead or alive, and we were able to interview 243 concerning many aspects of their lives. At least one-third of the original group had died during the 22-year period, representing standard mortality ratios 4.0 for males and 6.8 for females. Drug overdose, violence, alcohol, or suicide accounted for nearly all deaths of which the causes were known. Despite the availability of treatment, including methadone maintenance, both heroin use and criminality continued at a high rate. Of the 428 known survivors, 48% were currently enrolled in a methadone program after 22 years. They were using significantly less heroin, alcohol, and other drugs (except nicotine) than those not on methadone. Similar beneficial effects of methadone maintenance were reported retrospectively at interview. Our findings offer an insight into heroin addiction as a chronic lifelong relapsing disease with a high fatality rate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8745136     DOI: 10.1016/0376-8716(95)01205-2

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  29 in total

1.  Use of methadone.

Authors:  I B Anderson; T E Kearney
Journal:  West J Med       Date:  2000-01

Review 2.  Heroin maintenance for chronic heroin-dependent individuals.

Authors:  Marica Ferri; Marina Davoli; Carlo A Perucci
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 3.  Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS.

Authors:  L Degenhardt; W Hall; M Warner-Smith
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

4.  The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California.

Authors:  Emanuel Krebs; Darren Urada; Elizabeth Evans; David Huang; Yih-Ing Hser; Bohdan Nosyk
Journal:  Addiction       Date:  2017-02-06       Impact factor: 6.526

Review 5.  Characteristics and consequences of heroin use among older adults in the United States: a review of the literature, treatment implications, and recommendations for further research.

Authors:  Daniel Rosen; Amanda Hunsaker; Steven M Albert; Jack R Cornelius; Charles F Reynolds
Journal:  Addict Behav       Date:  2010-12-10       Impact factor: 3.913

6.  Hepatitis C seroprevalence among prison inmates since 2001: still high but declining.

Authors:  Aiden K Varan; Daniel W Mercer; Matthew S Stein; Anne C Spaulding
Journal:  Public Health Rep       Date:  2014 Mar-Apr       Impact factor: 2.792

7.  Mortality among heroin users and users of other internationally regulated drugs: A 27-year follow-up of users in the Epidemiologic Catchment Area Program household samples.

Authors:  Catalina Lopez-Quintero; Kimberly B Roth; William W Eaton; Li-Tzy Wu; Linda B Cottler; Martha Bruce; James C Anthony
Journal:  Drug Alcohol Depend       Date:  2015-09-03       Impact factor: 4.492

8.  In Their Own Voices: Breaking the Vicious Cycle of Addiction, Treatment and Criminal Justice Among People who Inject Drugs in Ukraine.

Authors:  Alyona Mazhnaya; Martha J Bojko; Ruthanne Marcus; Sergii Filippovych; Zahedsul Islam; Sergey Dvoriak; Frederick L Altice
Journal:  Drugs (Abingdon Engl)       Date:  2016-02-16

Review 9.  Economic evaluation of interventions to treat opiate dependence : a review of the evidence.

Authors:  Christopher M Doran
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

10.  Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years.

Authors:  Yih-Ing Hser; Elizabeth Evans; David Huang; Mary-Lynn Brecht; Libo Li
Journal:  Addict Behav       Date:  2008-08-08       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.